Status:
COMPLETED
Personalizing Window of Implantation During Frozen Embryo Transfer
Lead Sponsor:
Clinique Ovo
Collaborating Sponsors:
Ferring Pharmaceuticals
Conditions:
Fertility
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Embryo implantation is a crucial event in the establishment of a pregnancy. Although the clinical and culture conditions to obtain a "good quality" embryo are well advanced today, endometrial receptiv...
Eligibility Criteria
Inclusion
- Women between the ages of 18 to 40 inclusive at the time of oocyte retrieval
- Prescription of a single frozen embryo transfer - substituted cycle protocol
- Participant has at least 2 vitrified good quality blastocysts
Exclusion
- Women undergoing fertility preservation
- Stage IV severe endometriosis
- Severe malformation, adenomyosis or uterine anomaly including fibroids deforming the uterine cavity ≥ 5 cm
- Positive results of screening for either participant or partner for HIV antibodies, Hepatitis B (other than surface antibodies present after vaccination) or Hepatitis C
Key Trial Info
Start Date :
March 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 29 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04840121
Start Date
March 24 2021
End Date
January 29 2024
Last Update
February 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Ovo
Montreal, Quebec, Canada, H4P 2S4